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Abstract 
Background: Since the 2005 French law on end of life and patients’ rights, it is unclear 
whether practices have evolved. We investigated whether an intensive communication 
strategy based on this law would influence practices in terms of withholding and withdrawing 
treatment (WWT), and outcome of patients hospitalised in intensive care (ICU). 
Methods: Single-centre  two-period study, before and after the law. Between periods, an 
intensive strategy for communication was developed and implemented, comprising regular 
meetings and modalities for WWT. We examined medical records of all patients who died in 
the ICU or in-hospital during both periods.  
Results: In total, out of 2478 patients admitted in period 1, 678(31%) died in ICU and 
823/2940 (28%) in period 2. In period 1, among patients who died in ICU, 45% died further to 
a decision to WWT vs 85% in period 2 (p<0.01). Among these, median time delay between 
ICU admission and initiation of decision-making process was significantly different (6-7 days 
in period 1 vs 3-5 days in period 2, p<0.05). Similarly, median time from admission to actual 
WWT decision was significantly shorter in period 2 (11-13 days in period 1 vs 4-6 days in 
period 2, p<0.05). Finally, median time from admission to death in ICU further to a decision to 
WWT was 13-15 days in period 1 vs 7-8 days in period 2, p<0.05. Reasons for WWT were 
not significantly different between periods.  
Conclusion: Intensive communication brings about quicker end-of-life decision-making in 
the ICU. The new law has the advantage of providing a legal framework.  
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Introduction 
Since the advent of the discipline of critical care almost half a century ago, it has become 
clear that in some patients, there are limits to the therapeutic engagement. The use of all 
available resources to maintain artificial life support can sometimes border on the excessive, 
not to say unreasonable, given the hopeless prognosis and low quality of life expected for the 
patient, or the excessive economic cost [1-3]. 
Early studies exploring this concept led to the proposal of a scale of therapeutic engagement 
[4]. Further reports evaluating practices in terms of withholding and withdrawing treatment in 
critical care in France [1, 5] brought the medical community to a collective realisation that the 
conceptual framework needed to be reviewed. This ushered in an era of profound reflection 
on the role of the patient, their proxies, and the responsibility of physicians and paramedical 
staff in end-of-life decision-making. The results of this reflection have materialised in different 
forms in different countries, depending on the local legal and cultural context [6-11].  
In France, this process of reflection led to new legislation, dating from 22 April 2005, relative 
to patient rights at the end-of-life, the so-called “Leonetti” law [12-13]. Briefly, this law gives 
new rights to patients and clarifies medical practices regarding end-of-life care.  
We performed a before-and-after, interventional study to investigate whether an intensive 
communication strategy regarding end-of-life decisions, taking into account the dispositions 
of the law dated 22 April 2005, would have an influence on practices in terms of withholding 
and withdrawing treatment, and on the outcome of patients hospitalised in critical care.  
Methods 
This single-centre study was performed over two periods, namely before the law of 22 April 
2005, from January 2000-March 2005 (period 1), and after the law, from January 2006 to 
December 2009 (period 2). The institutional review board (Comité de Protection des 
Personnes, Dijon) approved the protocol.  
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Between the 2 phases, our healthcare team (physicians, nurses, nurses’ aids, psychologist) 
developed an intensive strategy for communication on the level of therapeutic engagement 
for every patient in the intensive care unit (ICU) according to clinical severity and expected 
prognosis. The communication strategy and related structural organisation within the 
department is described in Table 1.  
Data Collection 
We examined the medical records of all patients who died in the ICU or in-hospital after 
discharge to another department, during the two study periods.  
We recorded for all patients: age, sex, simplified acute physiological score (SAPS II) (17), 
comorbidities and diagnosis at admission as defined by the International Classification of 
Disease, 9th Ed, clinical Modification (ICD-9-CM); Knaus score (18), type of admission 
(medical or surgical), the person who initiated the decision-making process on withholding of 
withdrawal of treatment for each patient; reasons for withholding or withdrawing treatment 
(choice of prespecified items); whether an external expert was consulted (clinician specialist 
of the main disease presented by the patient); existence of any information concerning 
withholding or withdrawal of treatment emanating from the patient or their proxies; whether 
any end-of-life decisions were noted in the medical file; frequency of use of morphine and/or 
midazolam; whether the patient died in the ICU or in-hospital.  
Withholding was defined as a planned decision not to initiate treatment that was otherwise 
indicated. Withdrawal was defined as interruption of ongoing treatments. Withholding or 
withdrawal of treatment included the possibility that a patient could be transferred to another 
hospital Department with instructions not be to readmitted to the ICU. 
For all patients who had died in the ICU or in-hospital further to discharge from the ICU to 
another department in period 1, we examined the medical records to identify whether death 
was due to limitation or withdrawal of ongoing treatment; and in cases where a decision to 
withhold or withdraw treatment had been made, what had been the reasons for this decision.  
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Overall, 99% of all deaths from both periods were analysed.  
Data relating to advance directives were noted as « not applicable » in period 1, since they 
pre-dated the 2005 legislation. Similarly, the first data on officially appointed proxies 
appeared in 2002, when a specific law allowing for the appointment of surrogates was 
introduced and put in practice in all hospitals nationwide.  
It should be noted that the ICU comprised 8 beds in period 1, and 15 in period 2, with an 
intermediate transitional period with an incremental increase of capacity to 11 then 13 beds.  
 
Statistical Analysis 
Quantitative variables are presented as median [Interquartile range] and qualitative variables 
as number (percentage). Quantitative variables were compared using the Wilcoxon test and 
qualitative data with the Chi square test or Fisher’s exact test. All tests were two-tailed and a 
p-value <0.05 was considered statistically significant. Bonferroni correction for multiple 
comparisons was applied where appropriate. All analyses were performed using SAS version 
9.1 (SAS Institute, Cary, NC, USA).  
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Results 
In total, 2478 patients were admitted in period 1, of whom 520 (21%) died in critical care, and 
158 (10%) in-hospital after discharge from critical care. In period 2, 2940 patients were 
admitted, of whom 672 (23%) died in critical care, and 151 (5%) in-hospital.  
The baseline characteristics of all patients who died in critical care or in-hospital after 
discharge to another department are displayed in Table 2. 
Median age [IQR] was 65 [53-78] in period 1 and 66 [54-78] in period 2. Median [IQR] SAPS 
II scores were respectively 65 [57-72] and 63 [54-75] in periods 1 and 2. Most admissions 
were for medical pathologies (93% in period 1, 92% in period 2). Previous state of health as 
evaluated by the Knaus score did not differ significantly between periods. Similarly, no 
significant difference between periods was observed in admission diagnosis or comorbidities.  
In period 1, a written notification of a decision to withhold or withdraw treatment was found in 
the medical files of 306 (45%) patients who died , versus 700 (85%) in period 2 (p<0.01). The 
difference was statistically significant for withholding alone, withdrawal alone, and for 
withholding plus withdrawal (table 1).  
In the majority of cases, the decision with withhold or withdraw therapy was made in the 
critical care department (95% in period 1 vs 93% in period 2).  
For the subsequent analyses, we considered only the 306 patients in period 1 and the 700 
patients in period 2 who died further to a decision to withhold or withdraw treatment.  
Time between admission to ICU and initiation of end-of-life decision-making process 
(Table 3) 
The median time delay (in days) between admission to the ICU and the initiation of a 
decision-making process regarding possible withholding or withdrawal of therapy was 
significantly different between periods (Table 3). Similarly, the median time delay from 
admission to the actual decision to withhold or withdraw therapy was significantly shorter in 
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period 2 (Table 3). We also observed a statistically significant difference between periods in 
median time delays [IQR] (in days) from admission to death in ICU and in-hospital, further to 
a decision to withhold treatment, withdraw treatment, or both.  
 
Reasons for Withholding or Withdrawing Treatment in both periods (Table 4) 
The reasons leading to a decision to withhold or withdraw treatment were documented in 
68% of medical files in period 1 vs 99% in period 2 (p<0.01). There was no significant 
change in the main reasons cited in both periods, with the exception of expected future 
quality of life for the patient, which was cited significantly more frequently in period 2 as a 
reason for withholding or withdrawing therapy (See Electronic Supplementary Material). 
Similarly, there was also a significant difference between periods in the citation rate of non-
response to optimal therapy (Table 4).  
 
Persons who initiated the decision-making process (Table 5) 
The person(s) who initiated the decision-making process regarding the need to withhold or 
withdraw therapy (expressed as percent of patients) differed significantly between periods. In 
period 2, the process was more often initiated by close family members and non-physician 
staff members (nurses, nurses’ aids) and this information was significantly less frequently 
unknown. Only four patients had prepared advance directives (all in period 2).  
Use of morphine and midazolam during withholding or withdrawal of treatment (Table 
6) 
The pharmacological environment used for pain and anxiety relief in patients in whom a 
decision to withhold or withdraw treatment had been made showed significantly more 
frequent use of morphine and midazolam during period 2 as compared to period 1 (Table 6).  
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The information regarding any decision to withhold or withdraw treatment was given to the 
patient in 5% of cases in period 1, vs 9% in period 2 (p=NS). The same information was 
given to the families in 65% of patients in period 1 vs 95% in period 2 (p<0.01).  
An external expert (clinician from another discipline) was consulted in an advisory capacity 
for 45% of decisions to withhold or withdraw therapy in period 1 vs 65% in period 2 (p<0.01). 
Experts were mainly consulted by telephone in both periods (85% in period 1 vs 87% in 
period 2, p=NS). 
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Discussion 
Our study shows that the number of deaths occurring further to a decision to withhold or 
withdraw therapy in patients hospitalised in the ICU differed significantly between the period 
before the new French law on patients’ rights at the end-of-life (45%), and the period after 
the new legislation (85%), when an intensive communication strategy around the dispositions 
of this law had been put in place. This study mainly relates to the process of reflection and 
introspection concerning the ethics of end-of-life care, and how this process can and should 
become more consensual. The results of our intensive communication strategy have been to 
bring about a collective raising of awareness within the ICU. Official guidelines from national 
societies published in 2000 had previously made a start at laying down a framework for this 
difficult domain [14]. There was a clear need to allay the fears of caregivers who, although 
not trained in end-of-life care, were almost “obliged” to make difficult end-of-life decisions on 
a routine basis. Similarly, there was a need to communicate, in a clear and transparent 
manner, on the ethics of end-of-life decisions, and to allow all those involved in end-of-life 
care to have access to the medical and ethical knowledge that could help them to make and 
follow through on their decisions. 
Previous studies have reported death rates of 50% to 78% after WWT decisions [1, 15]. 
These studies were performed before the 2005 law and indeed, our results from period 1 are 
in line with these results, with 45% of deaths occurring further to a decision to forego therapy.  
The second period of our study, after the new French legislation of 2005, saw the rate of 
deaths after limiting of life-sustaining therapy increase to 85% in our department, which is 
coherent with the rates reported in other studies conducted after 2005 [2, 16-18]. It should be 
noted that studies conducted in different religious or geographic contexts, particularly within 
Europe, can give differing results.  
This could reflect not a true evolution in practices, but rather a better communication 
regarding what really happens, facilitated by the law of 2005, which rendered it easier to 
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make such decisions and note them in the patient’s file. By creating a legal framework for 
end-of-life decisions, the new law has helped to exculpate physicians who previously 
laboured in a no-man’s-land of uncertainty about the ethics of end-of-life practices.  
 
Our results further underline the importance of a clear decision-making procedure within an 
ICU that includes good communication and regular collegial meetings to facilitate discussion. 
The new strategy we introduced comprising open communication and daily meetings with all 
staff members made it possible for all relevant parties to advance their opinions and reach – 
within a shorter time frame – a consensual decision about WWT options. Again, before the 
law of 22 April 2005, physicians in France had great difficulty in making decisions pertaining 
to suspension of life-sustaining therapies, and it was especially problematic to document 
such a decision in the medical file. With the legal framework created by the new law, the 
decision-making process has been greatly facilitated, and has been greeted with widespread 
relief among the medical profession. In the study by Ferrand et al [1], among the patients in 
whom a decision to forego life-sustaining therapy was made, this decision was generally 
made within 2 days (in 40.5%), and within 30 days of admission to the ICU for 50%. In our 
study, the decision-making process was initiated after a median of 6-7 days in period 1, and 
3-5 days in period 2, leading to a decision being made within a median of 11-13 days vs 4-6 
days in period 1 vs 2 respectively. This clearly underlines that the greater communication 
facilitated the initiation of the decision-making process, even though the consequence was a 
significant reduction in the time delay to death.  
The main motives cited as justification for deciding to withhold or withdraw therapy did not 
change significantly after the new legislation, except for quality of life and non-response to 
maximal medical therapy, which were more frequently cited in the later period. (See 
Electronic Supplementary Material). The new law specifically mentions that excessively 
burdensome treatment should be avoided and future quality of life taken into consideration, 
whereby the likelihood of a very low future quality of life would be considered suitable 
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justification for WWT. Thus, these factors are legitimised by the law as reasons for foregoing 
life-sustaining therapy. In the literature, other reported reasons for suspending life-sustaining 
therapy include physical or psychological suffering, or economic reasons [1, 18]. However, 
cost was not a factor in our study, since in the French medical health system, neither the 
patients nor the doctors are directly concerned by the cost of care.  
eWe noted an increase in the proportion of end-of-life decisions initiated by the patient’s 
close family or the non-physician personnel (nurses, nurses’ aids). Several studies assessing 
the collegial nature of decisions to forego life-sustaining therapy mention the lack of 
communication and interaction between the caregivers and the patients’ close family 
members when discussing the patient’s future [19-21]. Indeed, Stricker et al highlighted the 
need for improved emotional support, coordination of care and communication in their study 
of family satisfaction among the relatives of 996 Swiss ICU patients [16, 22]. Therefore, it is 
of particular importance to have an intensive communication strategy involving all staff 
members as well as the patient’s family and/or appointed surrogates. Contrary to reports that 
nurses are not sufficiently involved in end-of-life decisions [1, 15, 23-34], we observed in our 
study that the intensive communication helped to increase the participation of nursing staff. 
Indeed, Ferrand et al previously reported that nurses often cited emotional distress as a 
source of dissatisfaction [35], whereas in our study, the greater implication of nurses in the 
end-of-life decision-making process may have helped them to avoid this moral distress 
through greater communication.  
The intensive communication strategy introduced in our department made it possible to 
identify at an earlier stage patients who were likely to later have withholding or withdrawal of 
treatment. In view of the fact that there is a now a legal basis for such decisions, perhaps it 
has simply become easier to reach such decisions. Despite the improvements achieved with 
an intensive communication strategy in our department after the new French legislation on 
end-of-life patient rights, there are undoubtedly several areas where there is still room for 
further progress. Many patients do not have officially appointed surrogates or proxies, and 
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the level of communication regarding this possibility could likely be improved. Secondly, 
external consultants are often just consulted by telephone. More active involvement in grand 
rounds or interprofessional meetings could help to yield a more positive contribution from 
outside experts. Third, while the new law lays down good principles for end-of-life care, these 
dispositions are of little use and impossible to put into application if the whole medical and 
non-physician staff is not sufficiently aware and involved. Thus, regular training and constant 
communication are necessary, as well as psychological support. End-of-life care should be 
seen as extending beyond the patient to include the patient’s family, and is not simply a 
question of treating a specific disease.  
Limitations  
This was a single-centre study, including mainly medical patients (90%). Thus, our results 
may not be extrapolated to all ICU populations, or multiple centres, as it would be difficult to 
obtain uniform practices. Secondly, data from period 1 were retrospective, and there were 
probably missing data or insufficiently exploited files. Thirdly, decisions to withhold or 
withdraw treatment were not generally made during the night or during the weekend, 
because of the absence of sufficient staff to guarantee the collegial decision-making 
procedures. e Fourthly, the person who initiated the decision-making process regarding end-
of-life options can be difficult to identify, particularly in period 1, where notations in the 
medical file were less frequent and less detailed. e Fifth, our strategy of intensive 
communication was developed as a policy in the department and is not necessarily replicable 
in other departments. In addition, it is not possible to conclude that the changes observed in 
our practices were due solely to the introduction of the new legislation. e Sixth, since the ICU 
capacity increased between periods, there is a possibility that the patient profile changed 
between periods. Lastly, while doctors in France are not directly concerned by the cost of 
care, we cannot exclude that economical considerations due to limited resources may have 
influenced their decisions to withhold or withdraw therapy. 
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Conclusions 
The new law of 2005 in France on patient rights at end-of-life has made it possible to 
introduce an active communication strategy regarding end-of-life decisions, with a true legal 
framework, probably limiting excessively burdensome treatment.  
Intensive communication makes it possible to identify earlier patients who are likely to evolve 
towards WWT, which brings about quicker decision-making regarding end-of-life in the ICU.  
We noted greater involvement of close family and nursing staff in initiating decisions relating 
to end-of-life. The new law has the advantage of providing a legal framework to free 
physicians of the burden of unguided decision-making in this difficult context.  
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Table 1: Description of the elements comprising the intensive communication strategy 
regarding end-of-life decisions implemented in the intensive care unit according to the 
French law of 22 April 2005 
Organisation: 
 Introduce unrestricted visiting hours 
 Increase availability of the caregiving team to discuss clinical evolution and therapeutic 
engagement 
 Assign a meeting room specifically reserved for meetings with patients’ families 
 Define fixed appointments with families for meetings, without interruptions (physicians’ 
telephones switched off) 
 Apprise entire caregiving team of new communication strategy (defined below) 
 Implement continuing medical education training in end-of-life ethics before introduction of 
new communication strategy 
Communication:  
 Daily meetings of the caregiving team and with the patient and/or their family to : 
o decide on the level of therapeutic engagement (according to diagnosis, prognosis, 
comorbidities, previous quality of life, life expectancy, patient’s wishes as expressed 
either directly or indirectly through advance directives) 
o define modalities for withholding or withdrawing treatment, in accordance with the 
2005 law, and initiate collegial procedure in concert with an outside expert 
o discuss options for use of pain and anxiety relieving medications. 
 Create a special “Ethics” section in every patient’s medical record, accessible to all 
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members of the caregiving team, to document all discussions and decisions relating to the 
level of therapeutic engagement 
 Organise debriefing for members of caregiving team to discuss emotionally stressful cases 
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Table 2: Main characteristics of patients who died in ICU or in-hospital during the two study 
periods  
Variable Period 1 
(n=678) 
Period 2 
(n=823) 
Age, years, median [IQR] 65 [53-78] 66 [54-78] 
Male sex, no. (%) 420 (62) 485 (59) 
Coexisting conditions, no. (%) 
Immunodepression 
  Of which cancer 
Chronic obstructive pulmonary disease 
Chronic heart failure 
Chronic renal failure 
Cirrhosis 
Diabetes Mellitus 
 
74 (8) 
61/74 (82) 
101 (15) 
61 (9) 
47 (7) 
41 (6) 
95 (14) 
 
81 (10) 
67/81 (83) 
115 (14) 
66 (8) 
57 (7) 
66 (8) 
107 (13) 
Knaus, n. (%) 
I 
II 
III 
IV 
 
74 (11) 
359 (53) 
189 (28) 
498 (8) 
 
99 (12) 
461 (56) 
197 (24) 
66 (8) 
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SAPS II, median [IQR] 65 [57-72] 63 [54-75] 
Category of admission, no. (%) 
Medical 
Scheduled surgery 
Emergency surgery 
 
630 (93) 
28 (4) 
20 (3) 
 
758 (92) 
41 (5) 
24 (3) 
Reason for ICU admission, no. (%) 
Acute respiratory failure 
Shock 
Coma 
Post-operative 
Acute renal failure 
Other 
 
387 (57) 
149 (22) 
61 (9) 
48 (7) 
20 (3) 
13 (2) 
 
478 (58) 
198 (24) 
58 (7) 
65 (8) 
8 (1) 
16 (2) 
Withholding only, no. (%)# 
Withdrawal only, no (%)# 
Both Withholding and withdrawal, no (%)# 
68 (10) 
102 (15) 
136 (20) 
165 (20) 
288 (35) 
247 (30) 
% Decisions to withhold or withdraw made in ICU 95 93 
#p<0.05 for comparison between periods; all other patients died with full support. 
IQR, Interquartile range. 
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Table 3. Time delay between admission and initiation of end-of-life decision-making process, actual decision to withhold or withdraw therapy, 
and death in ICU or in-hospital in the two study periods. 
 
 Period 1 
N=306  
Period 2 
N=700 
Time delay, days Withholding 
only 
N=68 
Withdrawal 
only 
N=102 
Withholding and 
Withdrawal 
N=136 
Withholding 
only 
N=165 
Withdrawal 
only 
N=288 
Withholding and 
Withdrawal 
N=247 
Initiation of decision-making 
process#, Median, [IQR] 
 
6 [3-9] 
 
7 [3-10] 
 
7 [4-10] 
 
3 [2-6] 
 
5 [2-7] 
 
5 [2-7] 
Decision#, Median [IQR] 11 [7-15] 13 [7-18] 11 [8-16] 4 [2-7] 6 [3-8] 6 [3-8] 
Death in ICU#, Median [IQR] 15 [11-21] 14 [9-17] 13 [10-19] 8 [6-13] 7 [4-9] 7 [4-9] 
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Death in-hospital#, Median [IQR] 25 [14-31] 15 [12-17] 14 [11-22] 11 [9-16] 8 [6-11] 10 [7-15] 
#p<0.05 between periods for each category 
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Table 4 : Reasons cited to justify a decision to withhold or withdraw therapy in periods 1 and 2. 
 
 Period 1 
N=306 
Period 2 
N=700 
Reason Withholding 
only 
N=68 
Withdrawal 
only 
N=102 
Withholding and 
Withdrawal 
N=136 
Withholding 
only 
N=165 
Withdrawal 
only 
N=288 
Withholding and 
Withdrawal 
N=247 
Age  22 (32%) 36 (35%) 45 (33%) 56 (34%) 106 (37%) 94 (38%) 
Previous autonomy 18 (27%) 21 (21%) 26 (19%) 31 (19%) 69 (24%) 44 (18%) 
Comorbidities 26 (39%) 42 (41) 39 (29%) 56 (34%) 103 (36%) 86 (35) 
Expected future quality of life 37 (54%) 48 (47%) 53 (39%) 79 (48%) 146 (51%) 132 (46%) 
Diagnosis at admission 8 (12%) 9 (9%) 20 (15%) 23 (14%) 32 (11%) 42 (17%) 
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Non-response to maximal therapy 37 (55%) 49 (48%) 18 (43%) 74 (45%) 147 (51%) 113 (46%) 
Multi-organ failure 14 (21%) 19 (19%) 20 (15%) 26 (16%) 49 (17%) 32 (13%) 
Totals exceed 100% as more than one reason could be cited for each decision to withhold or withdraw therapy.  
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Table 5 : Person who initiated the decision-making process in both periods  
 
 Period 1 
N=306 
Period 2 
N=700 
Person Withholding 
only 
N=68 
Withdrawal 
only 
N=102 
Withholding and 
Withdrawal 
N=136 
Withholding 
only 
N=165 
Withdrawal 
only 
N=288 
Withholding and 
Withdrawal 
N=247 
Patient 
Competent to make decision 
By advance directives 
  
2 (3%) 
N/A 
 
3 (3%) 
N/A 
 
6 (4%) 
N/A 
 
8 (5%) 
1 (0.5%) 
 
8 (3%) 
1 (0.3%) 
 
12 (5%) 
2 (0.8%) 
Close family members* 5 (8%) 7 (7%) 9 (7%) 30 (18%) 60 (21%) 47 (19%) 
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Appointed surrogate 7 (10%) 6 (6%) 6 (4%) 20 (12%) 32 (11%) 22 (9%) 
Non-physician caregiver (nurse, 
nurse’s aid)* 
5 (8%) 4 (4%) 14 (10%) 55 (33%) 83 (29%) 96 (39%) 
Medical staff (physician) 46 (68%) 66 (65%) 94 (69%) 119 (71%) 210 (73%) 170 (69%) 
Unknown* 16 (23%) 18 (18%) 26 (19%) 3 (2%) 1 (0.3%) 1 (0.4%) 
Totals exceed 100% as more than one person could initiate each decision to withhold or withdraw therapy simultaneously.  
*p<0.05 for comparison period 1 vs period 2 for each category 
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Table 6 : Use of morphine and midazolam during withholding or withdrawal of therapy in both periods.  
 
 Period 1 
N=306 
Period 2 
N=700 
Pain and Anxiety Relieving Medication Withholding 
only 
N=68 
Withdrawal 
only 
N=102 
Withholding and 
Withdrawal 
N=136 
Withholding 
only 
N=165 
Withdrawal 
only 
N=288 
Withholding and 
Withdrawal 
N=247 
Morphine* 2 (3%) 10 (10%) 20 (15%) 20 (12%) 167 (58%) 163 (66%) 
Midazolam* 2 (3%) 8 (8%) 17 (13%) 15 (9%) 129 (45%) 133 (54%) 
Totals exceed 100% as both drugs could be used in the same patient.  
*p<0.05 for comparison period 1 vs period 2 for the three categories 
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